372 related articles for article (PubMed ID: 34489113)
1. The ASAS-OMERACT core domain set for axial spondyloarthritis.
Navarro-Compán V; Boel A; Boonen A; Mease P; Landewé R; Kiltz U; Dougados M; Baraliakos X; Bautista-Molano W; Carlier H; Chiowchanwisawakit P; Dagfinrud H; de Peyrecave N; El-Zorkany B; Fallon L; Gaffney K; Garrido-Cumbrera M; Gensler LS; Haroon N; Kwan YH; Machado PM; Maksymowych WP; Poddubnyy D; Protopopov M; Ramiro S; Shea B; Song IH; van Weely S; van der Heijde D
Semin Arthritis Rheum; 2021 Dec; 51(6):1342-1349. PubMed ID: 34489113
[TBL] [Abstract][Full Text] [Related]
2. Instrument selection for the ASAS core outcome set for axial spondyloarthritis.
Navarro-Compán V; Boel A; Boonen A; Mease PJ; Dougados M; Kiltz U; Landewé RBM; Baraliakos X; Bautista-Molano W; Chiowchanwisawakit P; Dagfinrud H; Fallon L; Garrido-Cumbrera M; Gensler L; ElZorkany BK; Haroon N; Kwan YH; Machado PM; Maksymowych W; Molto A; de Peyrecave N; Poddubnyy D; Protopopov M; Ramiro S; Song IH; van Weely S; van der Heijde D
Ann Rheum Dis; 2023 Jun; 82(6):763-772. PubMed ID: 35680390
[TBL] [Abstract][Full Text] [Related]
3. Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey.
Boel A; Navarro-Compán V; Boonen A; Mease P; Kiltz U; Dougados M; Landewé R; van der Heijde D
J Rheumatol; 2021 Dec; 48(12):1810-1814. PubMed ID: 34334361
[TBL] [Abstract][Full Text] [Related]
4. Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews.
Andreasen RA; Kristensen LE; Baraliakos X; Strand V; Mease PJ; de Wit M; Ellingsen T; Hansen IMJ; Kirkham J; Wells GA; Tugwell P; Maxwell L; Boers M; Egstrup K; Christensen R
Arthritis Res Ther; 2020 Jul; 22(1):177. PubMed ID: 32711571
[TBL] [Abstract][Full Text] [Related]
5. ASAS consensus definition of early axial spondyloarthritis.
Navarro-Compán V; Benavent D; Capelusnik D; van der Heijde D; Landewé RB; Poddubnyy D; van Tubergen A; Baraliakos X; Van den Bosch FE; van Gaalen FA; Gensler L; López-Medina C; Marzo-Ortega H; Molto A; Pérez-Alamino R; Rudwaleit M; van de Sande M; Sengupta R; Weber U; Ramiro S
Ann Rheum Dis; 2023 Jun; ():. PubMed ID: 37321799
[TBL] [Abstract][Full Text] [Related]
6. How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review.
Bautista-Molano W; Navarro-Compán V; Landewé RB; Boers M; Kirkham JJ; van der Heijde D
Clin Rheumatol; 2014 Sep; 33(9):1313-22. PubMed ID: 24970597
[TBL] [Abstract][Full Text] [Related]
7. Assessing rheumatologists' attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort.
Rich-Garg N; Danve A; Choi D; Vakil-Gilani K; Akkoc N; Azevedo V; Russell A; Sharma A; Cush J; Curtis JR; Deodhar A
Clin Rheumatol; 2021 Mar; 40(3):949-954. PubMed ID: 32797363
[TBL] [Abstract][Full Text] [Related]
8. Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis.
Boel A; Navarro-Compán V; van der Heijde D
RMD Open; 2021 Dec; 7(3):. PubMed ID: 34893536
[TBL] [Abstract][Full Text] [Related]
9. How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice.
Kumthekar A; Sanghavi N; Natu A; Danve A
Curr Rheumatol Rep; 2024 May; 26(5):170-177. PubMed ID: 38372873
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Webers C; Ortolan A; Sepriano A; Falzon L; Baraliakos X; Landewé RBM; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):130-141. PubMed ID: 36270657
[TBL] [Abstract][Full Text] [Related]
11. Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2.
Navarro-Compán V; Ramiro S; Deodhar A; Mease PJ; Rudwaleit M; de la Loge C; Fleurinck C; Taieb V; Mørup MF; Massow U; Kay J; Magrey M
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599650
[TBL] [Abstract][Full Text] [Related]
12. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
13. Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings.
Aouad K; Wendling D; Breban M; Dadoun S; Hudry C; Moltó A; Pertuiset E; Gossec L
Rheumatology (Oxford); 2022 May; 61(6):2603-2608. PubMed ID: 34528070
[TBL] [Abstract][Full Text] [Related]
14. Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care.
Kiltz U; Wiatr T; Redeker I; Baraliakos X; Fedorov K; Braun J
Semin Arthritis Rheum; 2022 Aug; 55():152006. PubMed ID: 35472664
[TBL] [Abstract][Full Text] [Related]
15. The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders.
Ramiro S; Page MJ; Whittle SL; Huang H; Verhagen AP; Beaton DE; Richards P; Voshaar M; Shea B; van der Windt DA; Kopkow C; Lenza M; Jain NB; Richards B; Hill C; Gill TK; Koes B; Foster NE; Conaghan PG; Smith T; Malliaras P; Roe Y; Gagnier JJ; Buchbinder R
J Rheumatol; 2019 Aug; 46(8):969-975. PubMed ID: 30709947
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
Ortolan A; Webers C; Sepriano A; Falzon L; Baraliakos X; Landewé RB; Ramiro S; van der Heijde D; Nikiphorou E
Ann Rheum Dis; 2023 Jan; 82(1):142-152. PubMed ID: 36261247
[TBL] [Abstract][Full Text] [Related]
17. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
Osterhaus JT; Purcaru O
Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
[TBL] [Abstract][Full Text] [Related]
18. Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients.
Pike J; Dong Y; Piercy J; Booth N; Holdsworth E; Hunter T
Rheumatol Ther; 2021 Jun; 8(2):849-862. PubMed ID: 33864593
[TBL] [Abstract][Full Text] [Related]
19. Radiologic approach to axial spondyloarthritis: where are we now and where are we heading?
Kucybała I; Urbanik A; Wojciechowski W
Rheumatol Int; 2018 Oct; 38(10):1753-1762. PubMed ID: 30132215
[TBL] [Abstract][Full Text] [Related]
20. Axial Spondyloarthritis Treatment Recommendations and Disease Activity Monitoring in Clinical Practice: Results of an Online Survey.
Sinnappan S; Forte A; Ermann J
J Rheumatol; 2024 May; 51(5):472-478. PubMed ID: 38224985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
